SEC Form D · filed May 24, 2022
Kriya Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Shankar Ramaswamy · Redwood City, CAExec · DirectorRoger Jeffs · Redwood City, CADirectorDana Johnson · Redwood City, CAExecJames Momtazee · Redwood City, CADirectorIlan Oren · Redwood City, CADirectorSaira Ramasastry · Redwood City, CADirectorKeith Manchester · Redwood City, CADirectorC.R. Sincock · Redwood City, CADirectorNeelaksh Varshney · Redwood City, CADirectorWarren Rickards · Miami, FLDirectorFlowtrack Protocol Fund GP LLC · Miami, FLDirectorBen Somers · Miami, FLDirectorPaul G. Lukeman · Columbus, OHExec · DirectorBrennan P. Berry · Midland, TXDirectorFlowtrack Fund Management Company LLC · Miami, FLDirectorErp 1031 LLC · Midland, TXExecRamon Pitter · Miami, FLDirectorNeera Ravindran · Redwood City, CAExecIlise Lombardo · Redwood City, CAExecStephen Wilhite · Quincy, MADirectorRyan Letourneau · Quincy, MADirectorMatthieu Boujonnier · Quincy, MADirectorJeff D. Brown · Wheaton, ILDirectorStephen J. Elia · New York, NYDirectorMatt Posard · Menlo Park, CAExecSteven E. Decillis Ii · New York, NYDirectorJohn F. Cozzi · New York, NYExec · DirectorNeera Ravindran · Redwood City, CAExecNeelaksh Varshney · Redwood City, CADirectorIlise Lombardo · Redwood City, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗